Wells Fargo’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-860,762
| Closed | -$73.2M | – | 7419 |
|
|
2020
Q3 | $73.2M | Buy |
860,762
+221,882
| +35% | +$11.2M | 0.02% | 687 |
|
|
2020
Q2 | $22.6M | Sell |
638,880
-1,470,483
| -70% | -$43M | 0.01% | 1290 |
|
|
2020
Q1 | $28.4M | Sell |
2,109,363
-191,441
| -8% | -$3.22M | 0.01% | 1059 |
|
|
2019
Q4 | $48.7M | Buy |
2,300,804
+4,524
| +0.2% | +$79.8K | 0.01% | 942 |
|
|
2019
Q3 | $30.4M | Buy |
2,296,280
+541,959
| +31% | +$7.97M | 0.01% | 1176 |
|
|
2019
Q2 | $24.3M | Sell |
1,754,321
-17,064
| -1% | -$257K | 0.01% | 1352 |
|
|
2019
Q1 | $34M | Buy |
1,771,385
+230,896
| +15% | +$3.72M | 0.01% | 1115 |
|
|
2018
Q4 | $22M | Buy |
1,540,489
+1,164,608
| +310% | +$23.1M | 0.01% | 1319 |
|
|
2018
Q3 | $7.83M | Buy |
375,881
+23,676
| +7% | +$561K | ﹤0.01% | 2271 |
|
|
2018
Q2 | $8.34M | Sell |
352,205
-55,290
| -14% | -$1.11M | ﹤0.01% | 2221 |
|
|
2018
Q1 | $5.95M | Buy |
407,495
+18,558
| +5% | +$303K | ﹤0.01% | 2484 |
|
|
2017
Q4 | $6.29M | Buy |
388,937
+94,372
| +32% | +$1.11M | ﹤0.01% | 2387 |
|
|
2017
Q3 | $4.12M | Sell |
294,565
-3,466
| -1% | -$34.5K | ﹤0.01% | 2697 |
|
|
2017
Q2 | $2.63M | Buy |
298,031
+9,863
| +3% | +$69.3K | ﹤0.01% | 2981 |
|
|
2017
Q1 | $1.86M | Sell |
288,168
-23,928
| -8% | -$121K | ﹤0.01% | 3263 |
|
|
2016
Q4 | $1.15M | Buy |
312,096
+90,869
| +41% | +$269K | ﹤0.01% | 3595 |
|
|
2016
Q3 | $719K | Sell |
221,227
-6,446
| -3% | -$18K | ﹤0.01% | 3730 |
|
|
2016
Q2 | $529K | Buy |
227,673
+44,054
| +24% | +$147K | ﹤0.01% | 3881 |
|
|
2016
Q1 | $460K | Buy |
183,619
+67,647
| +58% | +$152K | ﹤0.01% | 3912 |
|
|
2015
Q4 | $356K | Buy |
115,972
+3,498
| +3% | +$9.76K | ﹤0.01% | 4112 |
|
|
2015
Q3 | $194K | Sell |
112,474
-82,311
| -42% | -$210K | ﹤0.01% | 4487 |
|
|
2015
Q2 | $791K | Buy |
194,785
+76,110
| +64% | +$311K | ﹤0.01% | 3786 |
|
|
2015
Q1 | $454K | Buy |
118,675
+61,075
| +106% | +$266K | ﹤0.01% | 4011 |
|
|
2014
Q4 | $276K | Sell |
57,600
-6,108
| -10% | -$24.1K | ﹤0.01% | 4261 |
|
|
2014
Q3 | $237K | Buy |
63,708
+43,117
| +209% | +$146K | ﹤0.01% | 4281 |
|
|
2014
Q2 | $75K | Buy |
20,591
+8,866
| +76% | +$32.5K | ﹤0.01% | 4811 |
|
|
2014
Q1 | $49K | Sell |
11,725
-1,332
| -10% | -$6.61K | ﹤0.01% | 4935 |
|
|
2013
Q4 | $60K | Sell |
13,057
-111
| -0.8% | -$494 | ﹤0.01% | 4692 |
|
|
2013
Q3 | $81K | Buy |
13,168
+4,515
| +52% | +$26K | ﹤0.01% | 4533 |
|
|
2013
Q2 | $47K | Buy |
+8,653
| New | +$28.4K | ﹤0.01% | 4639 |
|
Wells Fargo's IMMU Position: Q4 2020 in Review
Wells Fargo sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 860,762 shares — an estimated $73.2M sold.
Wells Fargo first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $73.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Wells Fargo reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Wells Fargo sold 860,762 Immunomedics Inc shares in Q4 2020, an estimated $73.2M.
- Wells Fargo first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Wells Fargo's Immunomedics Inc position peaked at $73.2M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.